640 related articles for article (PubMed ID: 23912965)
1. Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways.
Xu W; Wu W; Chen J; Guo R; Lin J; Liao X; Feng J
Int J Mol Med; 2013 Oct; 32(4):917-25. PubMed ID: 23912965
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
3. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways.
Xu W; Chen J; Lin J; Liu D; Mo L; Pan W; Feng J; Wu W; Zheng D
Int J Mol Med; 2015 Jan; 35(1):177-86. PubMed ID: 25412187
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells.
Chen J; Mo H; Guo R; You Q; Huang R; Wu K
Int J Mol Med; 2014 Mar; 33(3):605-12. PubMed ID: 24399619
[TBL] [Abstract][Full Text] [Related]
5. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
[TBL] [Abstract][Full Text] [Related]
6. Exogenous hydrogen sulfide alleviates high glucose-induced cardiotoxicity via inhibition of leptin signaling in H9c2 cells.
Zhuang XD; Hu X; Long M; Dong XB; Liu DH; Liao XX
Mol Cell Biochem; 2014 Jun; 391(1-2):147-55. PubMed ID: 24687304
[TBL] [Abstract][Full Text] [Related]
7. ATP-sensitive K⁺ channels contribute to the protective effects of exogenous hydrogen sulfide against high glucose-induced injury in H9c2 cardiac cells.
Liang W; Chen J; Mo L; Ke X; Zhang W; Zheng D; Pan W; Wu S; Feng J; Song M; Liao X
Int J Mol Med; 2016 Mar; 37(3):763-72. PubMed ID: 26820501
[TBL] [Abstract][Full Text] [Related]
8. Exogenous hydrogen sulfide ameliorates high glucose-induced myocardial injury & inflammation via the CIRP-MAPK signaling pathway in H9c2 cardiac cells.
Zhao HL; Wu BQ; Luo Y; Zhang WY; Hao YL; Liang JJ; Fang F; Liu W; Chen XH
Life Sci; 2018 Sep; 208():315-324. PubMed ID: 29857073
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
Liu MH; Lin XL; Zhang Y; He J; Tan TP; Wu SJ; Liu J; Tian W; Chen L; Yu S; Li J; Yuan C
Mol Med Rep; 2015 Nov; 12(5):6841-8. PubMed ID: 26299281
[TBL] [Abstract][Full Text] [Related]
10. Exogenous hydrogen sulfide protects against high glucose‑induced inflammation and cytotoxicity in H9c2 cardiac cells.
Huang Z; Dong X; Zhuang X; Hu X; Wang L; Liao X
Mol Med Rep; 2016 Nov; 14(5):4911-4917. PubMed ID: 27748941
[TBL] [Abstract][Full Text] [Related]
11. The Protective Effect of INH2BP, a Novel PARP Inhibitor 5-Iodo-6-Amino-1,2-Benzopyrone, Against Hydrogen Peroxide-Induced Apoptosis Through ERK and p38 MAPK in H9c2 Cells.
Back OC; Jang HS; Lee JS; Kim DE; Lee Y; Park ES; Kim IS
Pharmacology; 2015; 96(5-6):259-70. PubMed ID: 26550832
[TBL] [Abstract][Full Text] [Related]
12. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxia-induced injury in H9c2 cardiac myocytes.
Yang Z; Yang C; Xiao L; Liao X; Lan A; Wang X; Guo R; Chen P; Hu C; Feng J
Int J Mol Med; 2011 Sep; 28(3):397-403. PubMed ID: 21519787
[TBL] [Abstract][Full Text] [Related]
14. Exogenous sodium hydrosulfide protects against high glucose‑induced injury and inflammation in human umbilical vein endothelial cells by inhibiting necroptosis via the p38 MAPK signaling pathway.
Lin J; Li X; Lin Y; Huang Z; Wu W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215220
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide protects PC12 cells against reactive oxygen species and extracellular signal-regulated kinase 1/2-mediated downregulation of glutamate transporter-1 expression induced by chemical hypoxia.
Xiao L; Lan A; Mo L; Xu W; Jiang N; Hu F; Feng J; Zhang C
Int J Mol Med; 2012 Nov; 30(5):1126-32. PubMed ID: 22895544
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROS-activated ERK1/2 and p38MAPK signaling pathways in PC12 cells.
Lan A; Liao X; Mo L; Yang C; Yang Z; Wang X; Hu F; Chen P; Feng J; Zheng D; Xiao L
PLoS One; 2011; 6(10):e25921. PubMed ID: 21998720
[TBL] [Abstract][Full Text] [Related]
17. Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways.
Zhen Y; Zhang W; Liu C; He J; Lu Y; Guo R; Feng J; Zhang Y; Chen J
Oncol Rep; 2015 Nov; 34(5):2413-22. PubMed ID: 26351820
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
19. Exogenous hydrogen sulfide protects human umbilical vein endothelial cells against high glucose‑induced injury by inhibiting the necroptosis pathway.
Lin J; Chen M; Liu D; Guo R; Lin K; Deng H; Zhi X; Zhang W; Feng J; Wu W
Int J Mol Med; 2018 Mar; 41(3):1477-1486. PubMed ID: 29286079
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) protects cardiomyocytes against high glucose-induced injuries through inhibiting reactive oxygen species-activated leptin-p38 mitogen-activated protein kinase/extracellular signal-regulated protein kinase 1/2 pathways, but not the leptin-c-Jun N-terminal kinase pathway in vitro.
Lei Y; Xu Q; Zeng B; Zhang W; Zhen Y; Zhai Y; Cheng F; Mei W; Zheng D; Feng J; Lan J; Chen J
J Diabetes Investig; 2017 Jul; 8(4):434-445. PubMed ID: 27896943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
